The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion
Abstract
Ectopic ACTH syndrome (EAS) is rare but is frequently a severe condition because of the intensity of the hypercortisolism that may be dissociated from the tumoral condition. EAS should often be considered as an endocrine emergency requiring an emergency response both in terms of diagnostic procedures and therapeutic interventions. Patient management is complex and necessitates dual skills, in the diagnosis and treatment of CS and in the specific management of neuroendocrine tumors (NET). Therefore, initial management should be performed ideally by experienced endocrinology teams in collaboration with specialized hormonal laboratory, modern imaging platforms and intensive care units. Diagnostic procedures vary according to the endocrine and tumoral contexts but should be reduced to a minimum in intense hypercortisolism. Preventive and curative treatments of cortisol-induced comorbidities, non-specific management of hypercortisolism and etiological treatments should be considered simultaneously. Therapeutic strategies vary according to (1.) the intensity of hypercortisolism, the general condition of the patient and associated comorbidities and (2.) the tumoral status, ranging from resectable ACTH secreting tumors to non-resectable metastatic endocrine tumors or occult tumors. The ideal treatment is complete excision of the ACTH-secreting tumor that can be performed rapidly or after preoperative preparation using cortisol-lowering drugs. When this is not possible, the therapeutic strategy should be discussed by a multidisciplinary experienced team in a personalized perspective and include variable combinations of pharmacological agents, bilateral adrenalectomy and non-specific tumoral interventions. Here we discuss the diagnosis and therapeutic strategies including the modern, currently available tools and emphasize on the operational effectiveness of care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second-line tests include functional imaging using 68Ga-PET/CT or 18FDG PET/CT scans, which can be used to detect occult tumors, reinforce tumors seen on CT scan as being neuroendocrine, or contribute to the workup of metastatic tumors (9, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Desmopressin testing can also be used because type 2 vasopressin receptors, which are generally absent in normal pituitary corticotrophs, have found to be expressed in corticotroph adenomas.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Therefore, an increase in plasma ACTH and cortisol can be observed after injection of desmopressin in patients with Cushing disease (81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Dynamic testing with high-dose DST, CRH test, and desmopressin testing can also be used to help differentiate between Cushing disease and EAS (9, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“On the other hand, an absence of both ACTH and cortisol is expected in patients with EAS, although false-positive results can be seen as EAS tumors may express type 3 vasopressin receptors (9, 74, 81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Patients with EAS are typically unresponsive although some tumors, in particular bronchial carcinoids can express CRH receptors (9, 74, 81, 82).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“The CRH test is useful because corticotroph pituitary adenomas express CRH receptors and associated downstream cell-signaling pathway molecules, thereby responding to CRH by releasing excess ACTH compared with ectopic ACTH-secreting tumors (81).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
In the citing paper
“Therefore, most but not all patients with Cushing disease will have an increase in plasma ACTH by more than 50% and cortisol concentrations by more than 20% after CRH stimulation.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [81]
Citations
Cites
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Self-citationRindi, G., Klimstra, D. S., Abedi‐Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E. M., BUSAM, K. J., de Krijger, R. R., Dietel, M., El‐Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,164
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Pavel, M., Baudin, É., Couvelard, A., Krenning, E. P., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B. J., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 868
Oldfield, E. H., Doppman, J. L., Nieman, L. K., Chrousos, G. P., Miller, D. L., Katz, D. A., Cutler, G. B., & Loriaux, D. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251301 · Cited by 855
Caplin, M. E., Baudin, É., Ferollà, P., Filosso, P. L., García‐Yuste, M., Lim, E. K. S., Öberg, K., Pelosi, G., Perren, A. A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 713
Olsson, C. A., & Vickery, A. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197603252941310 · Cited by 711
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 667
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 615
Isidori, A. M., Kaltsas, G., Pozza, C., Frajese, V., Newell-Price, J. D. C., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 525
Sundin, A., Arnold, R., Baudin, É., Ćwikła, J. B., Eriksson, B. K., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjær, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000471879 · Cited by 500
Fleseriu, M., Biller, B. M. K., Findling, J. W., Molitch, M. E., Schteingart, D. E., Gross, C., on behalf of the SEISMIC Study Investigators, The SEISMIC Study Investigators include, Auchus, R., Bailey, T., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3350 · Cited by 479
Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study
Invitti, C., Giraldi, F. P., Martin, M. D., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.440 · Cited by 467
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419
The use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395
Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394
Diagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336
Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*
Nieman, L. K., Chrousos, G. P., Kellner, C. H., Spitz, I. M., NISULA, B. C., Cutler, G. B., Merriam, G. R., Bardin, C. W., & Loriaux, D. L. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-536 · Cited by 314
Verhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308
Prerequisite for Cardiac Aldosterone Action
Lombès, M., Alfaidy, N., Eugène, E., Lessana, A., Farman, N., & Bonvalet, J. P. (1995) · Circulation · doi:10.1161/01.cir.92.2.175 · Cited by 290
Clinical and Laboratory Studies of Ectopic Humoral Syndromes
Liddle, G. W., Nicholson, W. E., Island, D. P., Orth, D. N., Abe, K., & Lowder, S. C. (1969) · Elsevier eBooks · doi:10.1016/b978-0-12-571125-8.50009-0 · Cited by 280
High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines
Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02168.x · Cited by 278
Kaltsas, G., Giannulis, M. G., Newell-Price, J. D. C., Dacie, J. E., Thakkar, C., Afshar, F., Monson, J. P., Grossman, A. B., BESSER, G. M., & Trainer, P. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5437 · Cited by 233
Gushing syndrome doe to ectopic adrenocorticotropic hormone secretion
Aniszewski, J. P., Young, W. F., Thompson, G. B., Grant, C. S., & van Heerden, J. A. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0032-5 · Cited by 232
Aron, D. C., Raff, H., & Findling, J. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3991 · Cited by 223
Nieman, L. K., Oldfield, E. H., WESLEY, R. A., Chrousos, G. P., Loriaux, D. L., & Cutler, G. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077325 · Cited by 222
Kamenický, P., Droumaguet, C., Salenave, S., Blanchard, A., Jublanc, C., Gautier, J., Brailly‐Tabard, S., Leboulleux, S., Schlumberger, M. J., Baudin, É., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0536 · Cited by 218
Self-citationKetoconazole and Other Imidazole Derivatives as Inhibitors of Steroidogenesis
Feldman, D. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-409 · Cited by 217
Treatment of Cushing's Disease by o,p′DDD
LUTON, J. P., MAHOUDEAU, J. A., Bouchard, P., Thieblot, P., Hautecouverture, M., Simon, D., Laudat, M. H., Touitou, Y., & Bricaire, H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903013000903 · Cited by 208
Barrio, M. J., Czernin, J. G., Fanti, S., Ambrosini, V., Binse, I., Du, L., Eiber, M. J., Herrmann, K., & Fendler, W. P. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185587 · Cited by 207
Outcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review
Ritzel, K., Beuschlein, F., Mickisch, A., Oßwald, A., Schneider, H. J., Schopohl, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1470 · Cited by 201
Sarlis, N. J., Chanock, S. J., & Nieman, L. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6294 · Cited by 196
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.
Boscaro, M., Sonino, N., Scarda, A., Barzon, L., Fallo, F., Sartori, M., Patrassi, G., & Girolami, A. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.8.8703 · Cited by 195
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Bombardieri, E., Ambrosini, V., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Vecchio, S. D., Maffioli, L. S., Mortelmans, L., Oyen, W. J. G., Pepe, G., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1473-6 · Cited by 192
BERTAGNA, X. Y., Pivonello, R., Fleseriu, M., Zhang, Y., Robinson, P., Taylor, A. E., Watson, C. E., Maldonado, M., Hamrahian, A. H., Boscaro, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2117 · Cited by 191
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
Baudry, C., Coste, J., Bou Khalil, R., Silvera, S., Guignat, L., Guibourdenche, J., Abbas, H., Legmann, P., Bertagna, X., & Bertherat, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0358 · Cited by 187
Patronas, N. J., Bulakbaşı, N., Stratakis, C. A., Lafferty, A. R. A., Oldfield, E. H., Doppman, J. L., & Nieman, L. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021438 · Cited by 186
Findling, J. W., Kehoe, M. E., Shaker, J. L., & Raff, H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-408 · Cited by 186
Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion
Ejaz, S., Vassilopoulou‐Sellin, R., Busaidy, N. L., Hu, M. I.-N., Waguespack, S. G., Jiménez, C., Ying, A. K., Cabanillas, M. E., Abbara, M., & Habra, M. A. (2011) · Cancer · doi:10.1002/cncr.26029 · Cited by 179
Stewart, P. M., Walker, B., Holder, G., O’Halloran, D., & Shackleton, C. H. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530609 · Cited by 174
Association of Hypertension and Hypokalemia with Cushing's Syndrome Caused by Ectopic ACTH Secretion
Torpy, D. J., Mullen, N., Ilias, Ι., & Nieman, L. K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04419.x · Cited by 173
Preda, V. A., Sen, J., Karavitaki, N., & Grossman, A. B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0274 · Cited by 170
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Daffara, F., De Francia, S., Reimondo, G., Zaggia, B., Aroasio, E., Porpiglia, F., Volante, M., Termine, A., Di Carlo, F., Dogliotti, L., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0103 · Cited by 167
Metyrapone in long-term management of Cushing's disease.
Jeffcoate, W. J., REES, L. H., Tomlin, S., Jones, A. E., Edwards, C., & BESSER, G. M. (1977) · BMJ · doi:10.1136/bmj.2.6081.215 · Cited by 164
Fleseriu, M., Pivonello, R., Young, J., Hamrahian, A. H., Molitch, M. E., Shimizu, C., Tanaka, T., Shimatsu, A., White, T. A., Hilliard, A., et al. (2015) · Pituitary · doi:10.1007/s11102-015-0692-z · Cited by 155
Self-citationDeroose, C. M., Hindié, E., Kebebew, E., Goichot, B., Pacák, K., Taïeb, D., & Impériale, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179234 · Cited by 155
Isidori, A. M., Kaltsas, G., Mohammed, S., Morris, D. G., Jenkins, P. J., Chew, S. L., Monson, J. P., BESSER, G. M., & Grossman, A. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030510 · Cited by 153
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review
Isidori, A. M., Sbardella, E., Zatelli, M. C., Boschetti, M., Vitale, G., Colao, A. A. L., Pivonello, R., * ABC (Altogether to Beat Cushing's syndrome) 2013 Group collaborators, Albiger, N. M. E., Ambrogio, A. G., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1589 · Cited by 151
Newell-Price, J. D. C., Morris, D. G., Drake, W. M., Korbonits, M., Monson, J. P., BESSER, G. M., & Grossman, A. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8357 · Cited by 148
Veytsman, I. G., Nieman, L. K., & Fojo, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2775 · Cited by 147
Lefournier, V., Martinie, M., Vasdev, A., Bessou, P., Passagia, J., Labat-Moleur, F., Stürm, N., Bosson, J., BACHELOT, I., & Chabre, O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020374 · Cited by 146
Self-citationTabarin, A., Laurent, F., Catargi, B., Olivier‐Puel, F., Lescene, R., Berge, J., Galli, F. S., Drouillard, J., Roger, P., & Guerin, J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00541.x · Cited by 144
Self-citationCushing’s syndrome: from physiological principles to diagnosis and clinical care
Raff, H., & Carroll, T. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.282871 · Cited by 137
Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation
SCHTEINGART, D. E., TSAO, H. S., TAYLOR, C. I., MCKENZIE, A., VICTORIA, R., & THERRIEN, B. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-5-613 · Cited by 131
Incidence of adrenal crisis in patients with adrenal insufficiency
Smans, L. C. C. J., Van der Valk, E. S., Hermus, A. R. M. M., & Zelissen, P. M. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12865 · Cited by 127
Reimondo, G., Paccotti, P., Minetto, M. A., Termine, A., Stura, G., Bergui, M., Angeli, A., & Terzolo, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01776.x · Cited by 124
Wagner, J., Langlois, F., Lim, D. S. T., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00805 · Cited by 118
Differential Diagnosis and Imaging in Cushing's Syndrome
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.009 · Cited by 116
Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole
Corcuff, J., Young, J., Masquefa-Giraud, P., Chanson, P., Baudin, É., & Tabarin, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0913 · Cited by 114
Self-citationTabarin, A., GRESELLE, J. F., San‐Galli, F., Leprat, F., CAILLE, J. M., Latapie, J. L., GUERIN, J., & Roger, P. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-53 · Cited by 114
Self-citationDrake, W. M., Perry, L. A., Hinds, C., Lowe, D., Reznek, R. H., & BESSER, G. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5156 · Cited by 111
Monaghan, P. J., Owen, L. J., Trainer, P. J., Brabant, G., Keevil, B. G., & Darby, D. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011014 · Cited by 111
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J., LUTON, J. P., Clauser, É., & BERTAGNA, X. Y. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118547 · Cited by 108
Kuyumcu, S., Özkan, Z. G., Şanlı, Y., Yılmaz, E., Mudun, A., Adalet, İ., & Ünal, S. N. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0718-4 · Cited by 108
Kamp, K., Alwani, R. A., Korpershoek, E., Franssen, G. J. H., de Herder, W. W., & Feelders, R. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0968 · Cited by 108
SCHTEINGART, D. E., Lloyd, R. V., Akil, H., Chandler, W. F., Ibarra-Perez, G., ROSEN, S. G., & Ogletree, R. L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-770 · Cited by 107
Malchoff, C. D., Orth, D. N., Abboud, C. F., Carney, J. A., Pairolero, P. C., & Carey, R. M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90116-7 · Cited by 105
Hescot, S., Slama, A., Lombès, A., Paci, A., Remy, H., Leboulleux, S., Chadarévian, R., Trabado, S., Amazit, L., Young, J., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0368 · Cited by 104
Self-citationChow, J. T., Thompson, G. B., Grant, C. S., Farley, D. R., Richards, M. L., & Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03082.x · Cited by 102
Ectopic pro-opiomelanocortin syndrome
Beuschlein, F., & Hammer, G. D. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00025-1 · Cited by 101
Winquist, E., Laskey, J., Crump, M., Khamsi, F., & Shepherd, F. A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.157 · Cited by 100
Salenave, S., Gatta‐Cherifi, B., Pecheur, S., San‐Galli, F., Visot, A., Lasjaunias, P. L., Roger, P., Berge, J., Young, J., Tabarin, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031908 · Cited by 99
Self-citationZemskova, M., Gundabolu, B., Sinaii, N., Chen, C. C., Carrasquillo, J. A., Whatley, M. A., Chowdhury, I., Gharib, A. M., & Nieman, L. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2282 · Cited by 95
ACTH-secreting Pancreatic Neoplasms Associated With Cushing Syndrome
Maragliano, R., Vanoli, A., Albarello, L., Milione, M., Baştürk, O., Klimstra, D. S., Wachtel, A. E., Uccella, S., Vicari, E., Milesi, M., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000340 · Cited by 95
Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma
Kerkhofs, T. M. A., Baudin, É., Terzolo, M., Allolio, B., Chadarévian, R., Mueller, H. H., Skogseid, B. M., Leboulleux, S., Mantero, F., Haak, H. R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2281 · Cited by 94
Neary, N. M., Booker, O. J., Abel, B. S., Matta, J. R., Muldoon, N., Sinaii, N., Pettigrew, R. I., Nieman, L. K., & Gharib, A. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3754 · Cited by 93
Cabergoline plus Lanreotide for Ectopic Cushing's Syndrome
Pivonello, R., Ferone, D., Lamberts, S. W. J., & Colao, A. (2005) · New England Journal of Medicine · doi:10.1056/nejm200506093522322 · Cited by 91
Sharma, S. T., Raff, H., & Nieman, L. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2149 · Cited by 89
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study.
Davi, M., Cosaro, E., Piacentini, S., Reimondo, G., Albiger, N., Arnaldi, G., Faggiano, A., Mantovani, G., Fazio, N., Piovesan, A., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0809 · Cited by 89
THERAPY OF ENDOCRINE DISEASE: Steroidogenesis enzyme inhibitors in Cushing's syndrome
Daniel, E., & Newell-Price, J. D. C. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1014 · Cited by 88
Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study
Kamenický, P., Redheuil, A. B., Roux, C., Salenave, S., Kachenoura, N., Raissouni, Z., Macron, L., Guignat, L., Jublanc, C., Azarine, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1783 · Cited by 87
Self-citationVinolas, H., Grouthier, V., Mehsen-Cêtre, N., Boisson, A., Winzenrieth, R., Schaeverbeke, T., Mesguich, C., Bordenave, L., & Tabarin, A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13743 · Cited by 87
Self-citationde Bruin, C., Feelders, R. A., Waaijers, A. M., van Koetsveld, P. M., Sprij-Mooij, D. M., Lamberts, S. W. J., & Hofland, L. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0110 · Cited by 86
Malignant Hypertension Revisited—Does This Still Exist?
Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx008 · Cited by 83
The Ectopic Adrenocorticotropic Hormone Syndrome
Hayes, A. R., & Grossman, A. B. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.005 · Cited by 83
Liver injury associated with ketoconazole: Review of the published evidence
Greenblatt, H. K., & Greenblatt, D. J. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.400 · Cited by 82
Carideo, L., Prosperi, D., Panzuto, F., Magi, L., Pratesi, M. S., Rinzivillo, M., Annibale, B., & Signore, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071032 · Cited by 81
Tsagarakis, S., Christoforaki, M., Giannopoulou, H., Rondogianni, F., Housianakou, I., Malagari, C., Rontogianni, D. P., Bellenis, I., & Thalassinos, N. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030525 · Cited by 80
Neuroendocrine ACTH-Producing Tumor of the Thymus—Experience with 12 Patients over 25 Years
Neary, N. M., López-Chávez, A., Abel, B. S., Boyce, A. M., Schaub, N. P., Kwong, K. F., Stratakis, C. A., Moran, C. A., Giaccone, G., & Nieman, L. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3355 · Cited by 80
Valassi, E., Swearingen, B., Lee, H., Nachtigall, L. B., Donoho, D. A., Klibanski, A., & Biller, B. M. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1500 · Cited by 78
Carroll, T. B., Peppard, W. J., Herrmann, D. J., Javorsky, B. R., Wang, T. S., Patel, H., Zarnecki, K., & Findling, J. W. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00269 · Cited by 78
BERTAGNA, X. Y., Favrod-Coune, C. A., Escourolle, H., Beuzeboc, P., Christoforov, B., Girard, F., & LUTON, J. P. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-5-988 · Cited by 77
Drugs in the medical treatment of Cushing's syndrome
SCHTEINGART, D. E. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903413522 · Cited by 76
Glucocorticoid excess and hypertension
Baid, S. K., & Nieman, L. K. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0046-0 · Cited by 76
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Robelin, P., Hadoux, J., Forestier, J., Planchard, D., Hervieu, V., Berdelou, A., Scoazec, J., Valette, P., Leboulleux, S., Ducreux, M. P., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.02.002 · Cited by 75
Young, J., Deneux‐Tharaux, C., Grino, M., Oliver, C., Chanson, P., & SCHAISON, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4549 · Cited by 74
Self-citationHigh plasma proopiomelanocortin in aggressive adrenocorticotropin- secreting tumors
Raffin‐Sanson, M., Massias, J. F., Dumont, C., Raux-Demay, M. C., Proeschel, M. F., LUTON, J. P., & BERTAGNA, X. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954027 · Cited by 74
Vassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 74
Creemers, S. G., Feelders, R. A., de Jong, F. H., Franssen, G. J. H., de Rijke, Y. B., van Koetsveld, P. M., & Hofland, L. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00217 · Cited by 73
Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
Kaltsas, G., & Makras, P. (2010) · Neuroendocrinology · doi:10.1159/000314298 · Cited by 71
Karageorgiadis, A. S., Papadakis, G. Z., Biro, J., Keil, M. F., Lyssikatos, C., Quezado, M., Merino, M. J., Schrump, D. S., Kebebew, E., Patronas, N. J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2945 · Cited by 69
Cushing’s syndrome in multiple endocrine neoplasia type 1
Simonds, W. F., Varghese, S., Marx, S. J., & Nieman, L. K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04220.x · Cited by 67
Mifepristone: Treatment of Cushing's Syndrome
Sartor, O. A., & Cutler, G. B. (1996) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199606000-00024 · Cited by 67
Valassi, E., Tabarin, A., Brue, T., Feelders, R., Reincke, M., Netea-Maier, R., Tóth, M., Zacharieva, S., Webb, S., Tsagarakis, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0464 · Cited by 66
Self-citationYoung, J., Bertherat, J. Y., Vantyghem, M., Chabre, O., Senoussi, S., Chadarévian, R., Castinetti, F., _, _., _, _., Abeillon, J., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0886 · Cited by 65
Self-citationKETOCONAZOLE THERAPY IN CUSHING'S DISEASE
Angeli, A., & Frairia, R. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91482-5 · Cited by 63
Kasaliwal, R., Sankhe, S., Lila, A. R., Budyal, S. R., Jagtap, V. S., Sarathi, V., Kakade, H., Bandgar, T., Menon, P. S. N., & Shah, N. S. (2012) · Clinical Endocrinology · doi:10.1111/cen.12069 · Cited by 63
Diagnosis of Corticotropin-Producing Bronchial Carcinoid Tumors Causing Cushing's Syndrome
Leinung, M. C., Young, W. F., WHITAKER, M. D., Scheithauer, B. W., Trastek, V. F., & Kvols, L. K. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62142-9 · Cited by 62
Yogi-Morren, D., Habra, M. A., Faiman, C., Bena, J., Hatipoğlu, B., Kennedy, L., Weil, R. J., & Hamrahian, A. H. (2015) · Endocrine Practice · doi:10.4158/ep15662.or · Cited by 61
Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma
Baudry, C., Paepegaey, A. C., & Groussin, L. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1301428 · Cited by 60
Asa, S. L., Kovács, K., Dw, K., Marcon, N. E., & Platts, M. (1980) · PubMed · Cited by 60
Lefournier, V., Gatta‐Cherifi, B., Martinie, M., Vasdev, A., Tabarin, A., Bessou, P., Berge, J., BACHELOT, I., & Chabre, O. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6011-3 · Cited by 58
Self-citationde Bruin, C., Hofland, L. J., Nieman, L. K., van Koetsveld, P. M., Waaijers, A. M., Sprij-Mooij, D. M., van Essen, M., Lamberts, S. W. J., de Herder, W. W., & Feelders, R. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1264 · Cited by 58
Tsagarakis, S., Vassiliadi, D. A., Kaskarelis, I. S., Komninos, J., Souvatzoglou, E., & Thalassinos, N. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2691 · Cited by 57
The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome
Terzolo, M., Reimondo, G., Alı̀, A., Borretta, G., Cesario, F., Pia, A. R., Paccotti, P., & Angeli, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01260.x · Cited by 55
Chowdhury, I., Sinaii, N., Oldfield, E. H., Patronas, N. J., & Nieman, L. K. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03646.x · Cited by 55
Kuhn, J., Proeschel, M. F., Seurin, D., BERTAGNA, X. Y., LUTON, J. P., & Girard, F. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90443-9 · Cited by 54
Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy
Jia, R., Šulentić, P., Xu, J., & Grossman, A. B. (2017) · Neuroendocrinology · doi:10.1159/000472255 · Cited by 54
Ectopic Cushing's syndrome: experience from a tertiary care centre.
Bhansali, A. K., Walia, R., Rana, S. S., Dutta, P., Radotra, B. D., Khandelwal, N., & Bhadada, S. K. (2009) · PubMed · Cited by 53
Jacobsson, H., Larsson, P., Jonsson, C., Jussing, E., & Grybäck, P. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182485110 · Cited by 53
Therapeutic Strategies for the Treatment of Severe Cushing’s Syndrome
Alexandraki, K., & Grossman, A. B. (2016) · Drugs · doi:10.1007/s40265-016-0539-6 · Cited by 52
Morgat, C., Vélayoudom‐Céphise, F., Schwartz, P., Guyot, M., Gaye, D., Vimont, D., Schulz, J., Mazère, J., Nunes, M. L., Smith, D. M., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3319-3 · Cited by 52
Self-citationShepherd, F. A. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.5.863 · Cited by 51
Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy.
Zeiger, M. A., Fraker, D. L., Pass, H. I., Nieman, L. K., Cutler, G. B., Chrousos, G. P., & Norton, J. A. (1993) · PubMed · Cited by 50
Nella, A. A., Lodish, M. B., Fox, E., Balis, F. M., Quezado, M., Whitcomb, P. O., Derdak, J., Kebebew, E., Widemann, B. C., & Stratakis, C. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4340 · Cited by 50
Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer
Nagy-Mignotte, H., Shestaeva, O., Vignoud, L., Guillem, P., Ruckly, S., Chabre, O., Sakhri, L., Duruisseaux, M., Mousseau, M., Timsit, J., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000116 · Cited by 50
Self-citationVarlamov, E., Hinojosa-Amaya, J. M., Stack, M., & Fleseriu, M. (2019) · Pituitary · doi:10.1007/s11102-019-00972-w · Cited by 48
Markou, Α., Manning, P., Kaya, B., Datta, S. N., Bomanji, J. B., & Conway, G. S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01839 · Cited by 48
Boddaert, G., Grand, B., Pimpec‐Barthes, F. L., Cazes, A., BERTAGNA, X. Y., & Riquet, M. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.07.022 · Cited by 47
Honda, K., Hirayama, K., Kikuchi, I., Nagato, H., Tamai, H., & Sasazuki, T. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192418 · Cited by 47
Global clinical response in C ushing's syndrome patients treated with mifepristone
Katznelson, L. J., Loriaux, D. L., Feldman, D., Braunstein, G. D., SCHTEINGART, D. E., & Gross, C. (2013) · Clinical Endocrinology · doi:10.1111/cen.12332 · Cited by 45
Carey, R. M., Orth, D. N., & Hartmann, W. H. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-3-482 · Cited by 45
Gabi, J., Milhem, M., Tovar, Y. E., Karem, E., Gabi, A., & Khthir, R. A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00086 · Cited by 43
Cushing's Disease Presenting with Avascular Necrosis of the Hip: An Orthopedic Emergency
Koch, C. A., Tsigos, C., Patronas, N. J., & Papanicolaou, D. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3010 · Cited by 40
Cristante, J., Lefournier, V., Stürm, N., Passagia, J. G., Gauchez, A. S., Tahon, F., Cantin, S., Chabre, O., & Gay, E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00333 · Cited by 39
Self-citationEctopic Hormone‐Secreting Pheochromocytoma: A Francophone Observational Study
Kirkby‐Bott, J., Brunaud, L., Mathonet, M., Hamoir, E., Kraimps, J., Trésallet, C., Amar, L., Rault, A., Henry, J., & Carnaille, B. M. L. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1488-1 · Cited by 38
Barroso‐Sousa, R., Lerário, A. M., Evangelista, J., Papadia, C., Lourenço, D. M., Lin, C. S., Kulcsar, M. A. V., Fragoso, M. C. B. V., & Hoff, A. O. (2014) · Thyroid · doi:10.1089/thy.2013.0571 · Cited by 38
Management of Diabetes Mellitus in Cushing’s Syndrome
Munir, A., & Newell-Price, J. D. C. (2010) · Neuroendocrinology · doi:10.1159/000314316 · Cited by 37
Kondo, T., Matsuyama, R., Ashihara, H., Matsuo, Y., SASAKI, K., Goto, R., Kaoru, O. N. O., Takaki, Y., Honda, Y., Iyama, K.-I., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-179 · Cited by 37
Bayraktar, F., Kebapçılar, L., Koçdor, M. A., Asa, S. L., Yeşil, S., Canda, Ş., Demir, T., Saklamaz, A., Seçil, M., Akıncı, B., et al. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924154 · Cited by 36
Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT
Papadakis, G. Z., Bağcı, U., Sadowski, S. M., Patronas, N. J., & Stratakis, C. A. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000806 · Cited by 36
Raff, H. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.005 · Cited by 34
Scanagatta, P., Montresor, E., Pergher, S., Mainente, M., Bonadiman, C., Benato, C., Feil, B., Destefanis, M. L., Pea, M., Spinoso, A., et al. (2004) · PubMed · Cited by 34
Sawathiparnich, P., Sitthinamsuwan, P., Sanpakit, K., Laohapensang, M., & Chuangsuwanich, T. (2009) · Endocrine · doi:10.1007/s12020-009-9150-x · Cited by 32
Cheung, N. W., & Boyages, S. C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01461.x · Cited by 32
Chrisoulidou, A., Pazaitou‐Panayiotou, K., Georgiou, E., Boudina, M., Kontogeorgos, G., Iakovou, I. P., Efstratiou, I., Patakiouta, F., & Vainas, I. G. (2008) · HORMONES · doi:10.1007/bf03401514 · Cited by 31
Singer, J., Werner, F., Koch, C. A., Bartels, M., Aigner, T., Lincke, T., Faßhauer, M., & Paschke, R. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1243634 · Cited by 30
Rod, A., Voicu, M., Chiche, L., Bazille, C., Mittre, H., Louiset, E., & Reznik, Y. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0453 · Cited by 30
An Unusual Case of Ectopic ACTH Syndrome
Willhauck, M. J., Pöpperl, G., Rachinger, W., Giese, A., Auernhammer, C. J., & Spitzweg, C. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1297967 · Cited by 28
Park, S., Rhee, Y., Youn, J., Park, Y. N., Lee, S., Kim, D., Song, S. Y., & Lim, S. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-948212 · Cited by 25
Salenave, S., Bernard, V., Cao, C. D., Guignat, L., Bachelot, A., Leboulleux, S., Droumaguet, C., Bry‐Gauillard, H., Pierre, P. R., Crinière, L., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0670 · Cited by 24
Self-citationLangton, K., Grüber, M., Masjkur, J. R., Steenblock, C., Peitzsch, M., Meinel, J., Lenders, J. W. M., Bornstein, S. R., & Eisenhofer, G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1379497 · Cited by 22
Goroshi, M. R., Jadhav, S., Lila, A. R., Kasaliwal, R., Khare, S., Yerawar, C. G., Hira, P., Phadke, U., Shah, H., Lele, V. R., et al. (2016) · Endocrine Connections · doi:10.1530/ec-16-0010 · Cited by 22
Grünewald, T. G. P., von Luettichau, I., WELSCH, U. N., Dörr, H., Höpner, F., Kovács, K., Burdach, S. E. G., & Rabl, W. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0961 · Cited by 21
Bruno, O. D., Danilowicz, K., Manavela, M. P., Mana, D. L., & Rossi, M. (2010) · Endocrine Practice · doi:10.4158/ep09286.cr · Cited by 20
Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome
Wannachalee, T., Turcu, A. F., & Auchus, R. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13818 · Cited by 20
Metastatic acinic cell carcinoma of the parotid gland with ectopic ACTH syndrome
Jamieson, L., Taylor, S. M., Smith, A., Bullock, M. J., & Davis, M. (2007) · Otolaryngology · doi:10.1016/j.otohns.2006.04.009 · Cited by 20
Margaritora, S., Cardillo, G., Filosso, P., Novellis, P., Rapicetta, C., Carleo, F., Bora, G., Cesario, A., Stefani, A., Rossi, G., et al. (2015) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0035-1555125 · Cited by 20
Arlt, A., Harbeck, B., Anlauf, M., Alkatout, İ., Klöppel, G., Fölsch, U. R., Bewig, B., & Mönig, H. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1062729 · Cited by 20
Vahidi, S., Stewart, J., Amin, K., Racila, E. V., & Li, F. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23852 · Cited by 20
Tsirona, S., Tzanela, M., Botoula, E., Belenis, I., Rondogianni, D., & Tsagarakis, S. (2015) · Endocrine Practice · doi:10.4158/ep15647.or · Cited by 19
Pro-Opiomelanocortin Expression in a Metastatic Breast Carcinoma with Ectopic ACTH Secretion
Pelte, M., Schwaller, J., Cerrato, C., & Meier, C. A. (2004) · The Breast Journal · doi:10.1111/j.1075-122x.2004.21467.x · Cited by 19
Ollivier, M., Haissaguerre, M., Ferrière, A., & Tabarin, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0694 · Cited by 18
Self-citationMarques, P., Vieira, M. D. S., & Bugalho, M. J. (2014) · Endocrine · doi:10.1007/s12020-014-0352-5 · Cited by 17
Cushing's syndrome secondary to ectopic ACTH secretion from metastatic breast carcinoma
Wigg, S. J., Ehrlich, A. R., & Fuller, P. J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00726.x · Cited by 17
Francia, G., Davì, M. V., Montresor, E., Colato, C., Ferdeghini, M., & Cascio, V. L. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344109 · Cited by 17
Presentation of a Medullary Endocrine Neoplasia 2A Kindred with Cushing's Syndrome
Zaydfudim, V. M., Stover, D. G., Caro, S. W., & Phay, J. E. (2008) · The American Surgeon · doi:10.1177/000313480807400714 · Cited by 17
Bélissant, O., Nataf, V., Ohnona, J., Michaud, L., Zhang-Yin, J. T., Bertherat, J. Y., Chanson, P., Reznik, Y., Talbot, J., & Montravers, F. (2019) · Endocrine · doi:10.1007/s12020-019-02098-2 · Cited by 16
Rajeev, S. P., McDougall, S., Terlizzo, M., Palmer, D. H., Daousi, C., & Cuthbertson, D. J. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-70 · Cited by 16
Chan, C., & Roberts, J. M. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-221580 · Cited by 16
Schalin‐Jäntti, C., Asa, S. L., Arola, J. T., & Sane, T. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9228-5 · Cited by 15
Novel Functional Imaging of Neuroendocrine Tumors
Sundin, A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.04.003 · Cited by 15
Özbey, N., Bozbora, A., Kalayci, G., Kapran, Y., Yılmazbayhan, D., Dizdaroğlu, F., Orhan, Y., Sencer, E., & Molvalilar, S. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343771 · Cited by 14
Baba, M., & Ray, D. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0571-0 · Cited by 14
Gabriel, S., Garrigue, P., Dahan, L., Castinetti, F., Sebag, F. A., Baumstark, K., Archange, C., Jha, A., Pacák, K., Guillet, B. A., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13745 · Cited by 14
Fountas, A., Giotaki, Z., Ligkros, N., Tsakiridou, E. D., Tigas, S. K., Saeger, W., & Tsatsoulis, A. A. (2015) · Endocrine Pathology · doi:10.1007/s12022-015-9384-5 · Cited by 14
Hatipoğlu, E., Kepicoglu, H., Ruşen, E., Kabasakal, L., Gündoğdu, S., & Kadıoğlu, P. (2013) · PubMed · Cited by 13
Okumura, T., Takayama, S., Nishio, S., Miyakoshi, T., Noguchi, T., Kobayashi, T., Fukushima, T., Sekiguchi, N., Otsuki, T., Komatsu, M., et al. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13099 · Cited by 13
An Unusual Case of Ectopic Adrenocorticotropin Secretion
Trulea, M., Patey, M., Chaufour‐Higel, B., Bouquigny, F., Longuebray, A., Rousseaux, P., Pasqual, C., Tabarin, A., & Delemer, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1634 · Cited by 12
Self-citationTrott, M., Farah, G. M., Stokes, V. J., Wang, L. M., & Grossman, A. B. (2016) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-16-0018 · Cited by 12
Diverticular Perforation: A Fatal Complication to Forestall in Cushing Syndrome
Sater, Z. A., Jha, S., McGlotten, R., Hartley, I. R., Lakis, M. E., Araque, K., & Nieman, L. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00829 · Cited by 12
Cyclic ectopic Cushing's syndrome and somatostatin analogue treatment.
Falhammar, H. (2009) · PubMed · Cited by 11
Kaya, T. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/17198.7127 · Cited by 10
Mendoza, C. F., Ontiveros, P., Xibillé, D. X., & Rivera, M. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0031-4 · Cited by 8
Successful Metyrapone Therapy of the Ectopic ACTH Syndrome
Coll, R. (1968) · Archives of Internal Medicine · doi:10.1001/archinte.121.6.549 · Cited by 8
Shirahige, Y., Watanabe, T., Oki, Y., Sonoda, T., & Adachi, I. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01907.x · Cited by 7
Mediastinal paraganglioma presenting as an intracardiac mass with superior vena caval obstruction.
Sharma, S., Sharma, S., & Mukhopadhyay, S. (1993) · Thorax · doi:10.1136/thx.48.11.1181 · Cited by 7
Flohr, F., & Geddert, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmicm1010540 · Cited by 7
Dutta, D., Mukhopadhyay, S., Maisnam, I., Ghosh, S. K., Mukhopadhyay, P., & Chowdhury, S. (2012) · Thyroid · doi:10.1089/thy.2012.0027 · Cited by 4
Chabre, O., Cristante, J., Lefournier, V., & Gay, E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01384 · Cited by 3
Self-citation
Cited by
Sorted by citations
Baudin, É., Caplin, M. E., García‐Carbonero, R., Fazio, N., Ferollà, P., Filosso, P. L., Frilling, A., de Herder, W. W., Hörsch, D., Knigge, U., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.01.003 · Cited by 292
Reincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 273
Gadelha, M. R., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 183
Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome
Frete, C., Corcuff, J.-B., Kuhn, E., Salenave, S., Gaye, D., Young, J., Chanson, P., & Tabarin, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa409 · Cited by 110
Self-citationENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
Newell-Price, J. D. C., Nieman, L. K., Reincke, M., & Tabarin, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0352 · Cited by 96
Self-citation
Metadata
- Authors
- Young, J., Haissaguerre, M., Viera-Pinto, O., Chabre, O., Baudin, E., & Tabarin, A.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- 1Department of Endocrinology, Paris-Sud University and Paris Saclay University, Assistance Publique Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
- Université Joseph Fourier (FR)
- 4Endocrine Oncology and Nuclear Medicine Department, Gustave Roussy Cancer Institute, Paris-Sud University and Paris-Saclay University, Villejuif, France
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04
- Volume
- 182
- Issue
- 4
- Pages
- R29-R58
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W3003251208
- Cited by
- 232
- References
- 189
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 37 · 2023: 45 · 2022: 43 · 2021: 29 · 2020: 8
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- ectopic ACTH syndrome, Cushing's syndrome, hypercortisolism, neuroendocrine tumors, ACTH-secreting tumor, bilateral adrenalectomy, tumor resection, multidisciplinary management, endocrine emergencies
- MeSH terms
- ACTH Syndrome, Ectopic, Cushing Syndrome, Endocrinology, Humans, Treatment Outcome, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
